Winter-only treatment with omalizumab to prevent asthma exacerbations in children.

Funding Activity

Website
http://purl.org/au-research/grants/nhmrc/1021316

Funding Status
Closed

Does something not look right? The information on this page has been harvested from data sources that may not be up to date. We continue to work with information providers to improve coverage and quality. To report an issue, use the .

Funded Activity Summary

Acute exacerbations of asthma add considerably to the economic and social burden imposed by asthma. Current asthma treatment frequently controls underlying asthma but does not prevent acute exacerbations in exacerbation-prone asthmatics. This trial, based on our asthma research, provides new hope that acute asthma can be prevented.

Funded Activity Details

Start Date: 01-01-2012

End Date: 01-01-2014

Funding Scheme: Project Grants

Funding Amount: $738,855.00

Funder: National Health and Medical Research Council

Research Topics

ANZSRC Field of Research (FoR)

Respiratory Diseases

ANZSRC Socio-Economic Objective (SEO)

There are no SEO codes available for this funding activity

Other Keywords

allergy | asthma exacerbation | clinical trial | immunoglobulin E (IgE) | respiratory viruses

Related Links